Evidence map›Paper›PMID 35515104›Full record

ArticleFrontiers in oncology2022

Machine Learning-Based Prediction of Lymph Node Metastasis Among Osteosarcoma Patients.

Wenle Li, Yafeng Liu, Wencai Liu, Zhi-Ri Tang, Shengtao Dong, Wanying Li, Kai Zhang, Chan Xu, Zhaohui Hu, Haosheng Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Wenle LiDepartment of Orthopedics, Xianyang Central Hospital, Xianyang, China.
Yafeng LiuSchool of Medicine, Anhui University of Science and Technology, Huainan, China.
Wencai LiuDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhi-Ri TangSchool of Physics and Technology, Wuhan University, Wuhan, China.
Shengtao DongDepartment of Spine Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Wanying LiClinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Kai ZhangDepartment of Orthopedics, Xianyang Central Hospital, Xianyang, China.
Chan XuClinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Zhaohui HuDepartment of Spine Surgery, Liuzhou People's Hospital, Liuzhou, China.
Haosheng WangDepartment of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Zhi LeiChronic Disease Division, Luzhou Center for Dcontrol and Prevention, Luzhou, China.
Qiang LiuDepartment of Orthopedics, Xianyang Central Hospital, Xianyang, China.
Chunxue GuoBiostatistics Department, Hengpu Yinuo (Beijing) Technology Co., Ltd, Beijing, China.
Chengliang YinFaculty of Medicine, Macau University of Science and Technology, Macau, Macau SAR, China.
Xian Yang Central Hospital · CNAnhui University of Science and Technology · CNDalian Medical University · CNFirst Affiliated Hospital of Nanchang University · CNLiuzhou General Hospital · CNMacau University of Science and Technology · MOSecond Affiliated Hospital of Jilin University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Regional lymph node metastasis is a contributor for poor prognosis in osteosarcoma. However, studies on risk factors for predicting regional lymph node metastasis in osteosarcoma are scarce. This study aimed to develop and validate a model based on machine learning (ML) algorithms. Methods: A total of 1201 patients, with 1094 cases from the surveillance epidemiology and end results (SEER) (the training set) and 107 cases (the external validation set) admitted from four medical centers in China, was included in this study. Independent risk factors for the risk of lymph node metastasis were screened by the multifactorial logistic regression models. Six ML algorithms, including the logistic regression (LR), the gradient boosting machine (GBM), the extreme gradient boosting (XGBoost), the random forest (RF), the decision tree (DT), and the multilayer perceptron (MLP), were used to evaluate the risk of lymph node metastasis. The prediction model was developed based on the bestpredictive performance of ML algorithm and the performance of the model was evaluatedby the area under curve (AUC), prediction accuracy, sensitivity and specificity. A homemade online calculator was capable of estimating the probability of lymph node metastasis in individuals. Results: Of all included patients, 9.41% (113/1201) patients developed regional lymph node metastasis. ML prediction models were developed based on nine variables: age, tumor (T) stage, metastasis (M) stage, laterality, surgery, radiation, chemotherapy, bone metastases, and lung metastases. In multivariate logistic regression analysis, T and M stage, surgery, and chemotherapy were significantly associated with lymph node metastasis. In the six ML algorithms, XGB had the highest AUC (0.882) and was utilized to develop as prediction model. A homemade online calculator was capable of estimating the probability of CLNM in individuals. Conclusions: T and M stage, surgery and Chemotherapy are independent risk factors for predicting lymph node metastasis among osteosarcoma patients. XGB algorithm has the best predictive performance, and the online risk calculator can help clinicians to identify the risk probability of lymph node metastasis among osteosarcoma patients.

Indexed as

lymph node metastasismachine learning algorithmmulticenterosteosarcomaSEERweb calculator

Identifiers

PMID35515104
PMCPMC9067126
OpenAlexW4224269260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.